The experience of additional treatment of MDR-TB patients using autologous mesenchymal stem cells

I. A. Vasilyeva, A. G. Konoplyannikov, V. V. Erokhin, A. F. Tsyb, V. I. Chukanov, A. A. Danilenko (Moscow, Obninsk, Russian Federation)

Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Disease area: Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. A. Vasilyeva, A. G. Konoplyannikov, V. V. Erokhin, A. F. Tsyb, V. I. Chukanov, A. A. Danilenko (Moscow, Obninsk, Russian Federation). The experience of additional treatment of MDR-TB patients using autologous mesenchymal stem cells. Eur Respir J 2007; 30: Suppl. 51, 1326

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Adjuvant therapy with autologus mesenchymal stem cells in extensively drug-resistant pulmonary tuberculosis. A case study
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009


Potential role of autologous mesenchymal stromal cells in the treatment of multidrug and extensively drug-resistant tuberculosis
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016

Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis (M/XDR-TB): An open-label phase 1 safety trial
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014


Pulmonary mycobacterial infection in allogeneic hematopoietic stem cell transplanted (HSCT) patients: A study of 7 cases
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011

The first experience of therapeutic dendritic cells vaccine administration in patients with extensively drug resistant lung tuberculosis
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



The ability of autologous dendritic cells to destroy NSCLC cells in vitro
Source: Annual Congress 2007 - Biology in thoracic oncology
Year: 2007


Fibroblastic activity of sputum in COPD, patients undergoing hematopoietic stem cell transplantation and healthy subjects
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010

Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant
Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017
Year: 2018



Stem cells, their niches, and evolving concepts concerning cancer
Source: Annual Congress 2007 - Stem cells and the lung: the road from basics to clinics
Year: 2007


The influence of conventional and targeted chemotherapy on the expression of stem cell markers in lung cancer cell lines
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017



Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007


Treatment results and follow up of patients with chronic multidrug resistant tuberculosis
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005


Localisation of endothelial progenitor cells (EPC) in NSCLC patients and sensitivity of EPC to chemotherapeutic agents in vitro
Source: Eur Respir J 2004; 24: Suppl. 48, 4s
Year: 2004

Comparison of two different cohorts of patients for multidrug-resistant tuberculosis treatment evaluation
Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB)
Year: 2006


Peripheral blood leukocyte subsets as markers of early TB treatment response
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005


Utility of bronchoscopy in hematopoietic stem cell transplant (HSCT) patients with pulmonary infiltrates: A prospective study.
Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised
Year: 2021


Tuberculosis therapy: past, present and future
Source: Eur Respir J 2002; 20: 87S-94S
Year: 2002



Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010

Diagnostic value of bronchoalveolar lavage cell differentiation in patients with pulmonary complications after high dose chemotherapy and hematopoietic stem cell transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 471s
Year: 2002

Oral presentation: Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009